Cellbxhealth PLC
ANPCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3 | $2 | $1 | $1 |
| % Growth | 30.9% | 110% | 2.8% | – |
| Cost of Goods Sold | $1 | $3 | $0 | $0 |
| Gross Profit | $2 | -$0 | $1 | $1 |
| % Margin | 62.2% | -18.7% | 58.9% | 70.2% |
| R&D Expenses | $2 | $10 | $11 | $8 |
| G&A Expenses | $0 | $0 | $1 | $0 |
| SG&A Expenses | $0 | $0 | $1 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $15 | $11 | $13 | $9 |
| Operating Expenses | $17 | $21 | $25 | $18 |
| Operating Income | -$15 | -$22 | -$24 | -$17 |
| % Margin | -527.5% | -995.4% | -2,325.4% | -1,701.4% |
| Other Income/Exp. Net | $0 | $0 | -$0 | -$0 |
| Pre-Tax Income | -$15 | -$22 | -$24 | -$17 |
| Tax Expense | -$1 | -$2 | -$3 | -$2 |
| Net Income | -$14 | -$20 | -$22 | -$15 |
| % Margin | -497% | -921% | -2,083.2% | -1,481.9% |
| EPS | -0.048 | -0.077 | -0.088 | -0.067 |
| % Growth | 37.6% | 12.1% | -31.8% | – |
| EPS Diluted | -0.048 | -0.077 | -0.088 | -0.067 |
| Weighted Avg Shares Out | 295 | 260 | 247 | 225 |
| Weighted Avg Shares Out Dil | 295 | 260 | 247 | 225 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $2 | $1 | $1 |
| EBITDA | -$13 | -$19 | -$24 | -$16 |
| % Margin | -455.1% | -869.1% | -2,342.7% | -1,551.7% |